Abstract | BACKGROUND: OBJECTIVE: To determine whether antiviral treatment helps reduce PHN-associated pain. DESIGN: Prospective, open-label phase I/II clinical trial. SETTING: Tertiary care university hospital. PATIENTS: Fifteen patients with moderate to severe PHN. INTERVENTIONS: Intravenous acyclovir at a dosage of 10 mg/kg every 8 hours for 14 days followed by oral valacyclovir at a dosage of 1000 mg 3 times per day for 1 month. MAIN OUTCOME MEASURE: Numeric Rating Scale for Pain score. RESULTS: As defined by a decrease of 2 or more points on the Numeric Rating Scale for Pain, 8 (53%) of 15 patients reported improvement. CONCLUSION: Clinical improvement reported by most of our patients warrants further investigation in a larger, randomized, double-blind, placebo-controlled trial.
|
Authors | Dianna Quan, Barbara N Hammack, John Kittelson, Donald H Gilden |
Journal | Archives of neurology
(Arch Neurol)
Vol. 63
Issue 7
Pg. 940-2
(Jul 2006)
ISSN: 0003-9942 [Print] United States |
PMID | 16682531
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiviral Agents
- Valine
- Valacyclovir
- Acyclovir
|
Topics |
- Acyclovir
(administration & dosage, adverse effects, analogs & derivatives)
- Administration, Oral
- Aged
- Aged, 80 and over
- Antiviral Agents
(administration & dosage, adverse effects)
- Drug Therapy, Combination
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Neuralgia, Postherpetic
(drug therapy)
- Prospective Studies
- Treatment Outcome
- Valacyclovir
- Valine
(administration & dosage, adverse effects, analogs & derivatives)
|